208 related articles for article (PubMed ID: 38811625)
1. TGF-β1 induces formation of TSG-6-enriched extracellular vesicles in fibroblasts which can prevent myofibroblast transformation by modulating Erk1/2 phosphorylation.
Ilg MM; Bustin SA; Ralph DJ; Cellek S
Sci Rep; 2024 May; 14(1):12389. PubMed ID: 38811625
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease.
Ilg MM; Stafford SJ; Mateus M; Bustin SA; Carpenter MJ; Muneer A; Bivalacqua TJ; Ralph DJ; Cellek S
J Sex Med; 2020 Oct; 17(10):1848-1864. PubMed ID: 32771352
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Role of Adenosine Receptors in the Myofibroblast Transformation in Peyronie's Disease.
Mateus M; Ilg MM; Stebbeds WJ; Christopher N; Muneer A; Ralph DJ; Cellek S
J Sex Med; 2018 Jul; 15(7):947-957. PubMed ID: 29891411
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin and the Rho-kinase inhibitor Y-27632 prevent myofibroblast transformation in Peyronie's disease-derived fibroblasts via inhibition of YAP/TAZ nuclear translocation.
Milenkovic U; Ilg MM; Zuccato C; Ramazani Y; De Ridder D; Albersen M
BJU Int; 2019 Apr; 123(4):703-715. PubMed ID: 30536599
[TBL] [Abstract][Full Text] [Related]
6. Estradiol attenuates the TGF-β1-induced conversion of primary TAFs into myofibroblasts and inhibits collagen production and myofibroblast contraction by modulating the Smad and Rho/ROCK signaling pathways.
Jiang HS; Zhu LL; Zhang Z; Chen H; Chen Y; Dai YT
Int J Mol Med; 2015 Sep; 36(3):801-7. PubMed ID: 26179216
[TBL] [Abstract][Full Text] [Related]
7. Temporal gene signature of myofibroblast transformation in Peyronie's disease: first insights into the molecular mechanisms of irreversibility.
Ilg MM; Harding S; Lapthorn AR; Kirvell S; Ralph DJ; Bustin SA; Ball G; Cellek S
J Sex Med; 2024 Mar; 21(4):278-287. PubMed ID: 38383071
[TBL] [Abstract][Full Text] [Related]
8. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
9. Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie's disease.
Ilg MM; Ralph DJ; Cellek S
J Sex Med; 2023 Jun; 20(7):925-934. PubMed ID: 37082866
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histone deacetylase 2 mitigates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Ryu JK; Kim WJ; Choi MJ; Park JM; Song KM; Kwon MH; Das ND; Kwon KD; Batbold D; Yin GN; Suh JK
Asian J Androl; 2013 Sep; 15(5):640-5. PubMed ID: 23770939
[TBL] [Abstract][Full Text] [Related]
11. Reduction in Peyronie's-like plaque size using a vacuum erection device in a rat model of Peyronie's disease via the TGF-β/SMAD signalling pathway.
Li J; Wang S; Qin F; Zhu M; You X; Wu C; Fu F; Yuan J
Andrologia; 2018 Sep; 50(7):e13051. PubMed ID: 29806152
[TBL] [Abstract][Full Text] [Related]
12. Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
Peng H; Carretero OA; Peterson EL; Rhaleb NE
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1357-64. PubMed ID: 20154264
[TBL] [Abstract][Full Text] [Related]
13. Effect of SMAD7 gene overexpression on TGF-β1-induced profibrotic responses in fibroblasts derived from Peyronie's plaque.
Choi MJ; Song KM; Park JM; Kwon MH; Kwon KD; Park SH; Ryu DS; Ryu JK; Suh JK
Asian J Androl; 2015; 17(3):487-92. PubMed ID: 25532569
[TBL] [Abstract][Full Text] [Related]
14. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.
Jung KH; Ryu YL; Lee HS; Lee H; Son MK; Yan HH; Hong SW; Ryu JK; Hong S; Suh JK; Hong SS
Int J Oncol; 2013 Jun; 42(6):2001-8. PubMed ID: 23588860
[TBL] [Abstract][Full Text] [Related]
15. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
16. Nintedanib inhibits TGF-β-induced myofibroblast transdifferentiation in human Tenon's fibroblasts.
Lin X; Wen J; Liu R; Gao W; Qu B; Yu M
Mol Vis; 2018; 24():789-800. PubMed ID: 30636861
[TBL] [Abstract][Full Text] [Related]
17. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model.
Vernet D; Ferrini MG; Valente EG; Magee TR; Bou-Gharios G; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2002 Dec; 7(4):262-76. PubMed ID: 12446175
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
Sobel K; Menyhart K; Killer N; Renault B; Bauer Y; Studer R; Steiner B; Bolli MH; Nayler O; Gatfield J
J Biol Chem; 2013 May; 288(21):14839-51. PubMed ID: 23589284
[TBL] [Abstract][Full Text] [Related]
19. Cub domain-containing protein 1 negatively regulates TGF-β signaling and myofibroblast differentiation.
Noskovičová N; Heinzelmann K; Burgstaller G; Behr J; Eickelberg O
Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L695-L707. PubMed ID: 29351434
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.
Bondi CD; Manickam N; Lee DY; Block K; Gorin Y; Abboud HE; Barnes JL
J Am Soc Nephrol; 2010 Jan; 21(1):93-102. PubMed ID: 19926889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
